Answers are grounded in this paper and cite their sources.
Platelet-rich plasma releasate counteracts effects of an inflammatory environment on genes regulating matrix degradation and formation in human chondrocytes. Platelet-rich plasma releasate decreases NFκB activation, a major pathway involved in the pathogenesis of OA. These results encourage further study of PRP as a treatment for OA.
No takes yet. Share an insight, caveat, or question.
Buul et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: